Big DataCorporateNews

Indian AI start-up SigTuple gets $5.8 million funding

SigTuple, healthcare start-up, working in the field of artificial intelligence for diagnosis, announced series A funding of US$5.8 million. This is the largest investment in a healthcare AI startup out of India. It will help SigTuple scale up and go global. This round of funding was led by Accel Partners with participation from IDG Ventures, Endiya Partners, pi Ventures, VH Capital and Axilor Partners and other prominent investors including Sachin Bansal, Binny Bansal, Amit Singhal (SVP Engineering, Uber and Ex-SVP, Google Search).

Earlier, ( Oct 2015) the company had raised $740,000 seed funding from Sachin Bansal, Binny Bansal, Accel Partners, Ashok Bareja, Dr. Nirupa Bareja and Debanjan Mukherjee. SigTuple intends to use the latest round of funding to expand the team, bullet-proof the platform and the product for user adoption followed by commercials, and regulatory clearances for global markets.

SigTuple is solving some of the most advanced research problems arising out of an unprecedented application of recent advances in AI to the medical domain. From crunching through microscopy images of blood to quantify normal and abnormal blood cells, to tracking sperm cells in microscopy videos, to localizing pathologies in retinal scan images, we are at the bleeding edge of things. Research in core AI, computer vision and extreme platform engineering are an integral part of our journey.

SigTuple’s solutions will allow labs and hospitals to scale by implementing a hub and spoke model where the medical experts can operate from hub and devices can be installed in spokes. The solution will be available at a very affordable price and will enable labs to adopt technology without changing the hardware. It will improve the efficiency of medical experts by automating painful and fatigue driven visual medical analysis process.

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.
Tags
Show More

Related Articles

Leave a Reply

Close